Jardiance Cost Guide: Prices, Savings, & Patient Assistance

Understanding the True Cost of Jardiance (Empagliflozin)

Jardiance (empagliflozin) is a powerful, brand-name medication approved for the treatment of Type 2 diabetes, heart failure, and chronic kidney disease. Because of its broad utility and brand-name status, the cost can be exceptionally high. Navigating this cost requires a detailed understanding of the factors that determine your final out-of-pocket payment.

Direct Answer: What is the Average Cash Price of a 30-Day Supply?

Without insurance, discounts, or financial assistance, the average retail cash price for a 30-day supply of Jardiance (either the 10mg or 25mg dosage strength) typically ranges from $750 to over $875. While the manufacturer’s list price is lower, the final price set by individual pharmacies, before any savings are applied, is what determines the full cash price.

The good news is that very few people pay this maximum price. The actual final out-of-pocket cost is highly variable, depending on your insurance status, the specific pharmacy you use, your location, and whether you are eligible for savings programs. For commercially insured patients or those utilizing manufacturer assistance, the cost often drops significantly, ranging from $0 to $50 for eligible patients.

Establishing Expertise: Why Prescription Costs Vary Wildly

The dramatic fluctuation in the price of brand-name medications like Jardiance stems from a complex, non-transparent pricing structure involving manufacturers, pharmacy benefit managers (PBMs), and health insurers. Based on extensive pharmaceutical market analysis, the primary factors influencing your payment are:

  • Insurance Formulary Status: Whether your insurance company’s list of covered drugs (formulary) places Jardiance on Tier 1 (lowest cost, generic), Tier 2 (preferred brand), or Tier 3/4 (non-preferred or specialty, highest cost).
  • The Dosage is Irrelevant: For Jardiance, the dosage strength (10mg vs. 25mg) generally does not change the co-pay or final cash price, as both are priced as premium, brand-name drugs.
  • Pharmacy Choice: Retail pharmacies can set their own prices for cash-paying customers. Shopping around—especially checking prices at warehouse clubs, major retail chains, and reputable online pharmacies—can save hundreds of dollars.

This comprehensive guide is designed to provide a transparent breakdown of every cost factor and offer actionable methods to drastically reduce your monthly prescription cost for Jardiance, ensuring you can afford the vital treatment prescribed by your doctor.

Jardiance Cost Without Insurance: Full Price vs. Discounted Rates

For the estimated 27 million Americans who are uninsured or underinsured, the cash price of essential brand-name medications like Jardiance (empagliflozin) can be a significant financial burden. While insurance coverage often complicates the final out-of-pocket cost, understanding the full retail price is the first and most critical step in finding a path to savings.

The Full Retail Cash Price Breakdown (10mg vs. 25mg)

The manufacturer’s official list price for a 30-day supply of Jardiance is approximately $630. However, the price you pay at the pharmacy counter—known as the average retail cash price—is typically much higher due to pharmacy markups and dispensing fees. On average, an individual without insurance or discounts should expect to pay over $760 for a 30-day supply of either the 10mg or 25mg tablets.

Based on current pharmacy data, the price for a one-month supply of Jardiance can vary significantly depending on where you fill the prescription. To illustrate this wide price range, here is a comparison of typical cash prices at major national chains, demonstrating the need to shop around:

Pharmacy Chain Estimated 30-Day Cash Price Range
CVS Pharmacy $$$747 – $$$760
Walgreens $$$755 – $$$770
Walmart $$$750 – $$$765

The high cost of this medication for type 2 diabetes, heart failure, and chronic kidney disease can reach over $$9,100$ per year, reinforcing why proactive cost-saving strategies are essential for medication adherence.

Maximizing Savings with Prescription Discount Cards and Pharmacy Deals

The most immediate and accessible way for uninsured patients to reduce the cash price is by utilizing free prescription discount cards. These programs negotiate lower prices directly with the pharmacy and are not tied to your insurance status—meaning anyone can use them to save money on the full retail cost.

A simple search and application of a free discount card (such as GoodRx or SingleCare) can instantly reduce the cash price by hundreds of dollars. Instead of paying the full retail price, patients who use one of these digital coupons typically see the cost drop to an estimated range of $530–$630 for a 30-day supply of Jardiance. Given that the average retail price is over $$760$, leveraging one of these free tools provides an essential saving of over $$100$ per month. This practice, along with comparing prices across different pharmacies, is widely recommended by financial health experts as a core step in reducing the burden of brand-name prescription costs.

The Role of Deductibles, Co-pays, and Co-insurance in Total Cost

For the vast majority of patients in the United States, the ultimate out-of-pocket cost for a brand-name medication like Jardiance is determined by their commercial health insurance plan. The primary factor is the drug’s placement on the plan’s formulary (the list of covered drugs). Jardiance is typically considered a non-preferred brand or Tier 3/Tier 4 specialty medication due to its cost and the availability of lower-priced alternatives or generics for older diabetes and heart treatments.

Once you have met your plan’s annual deductible, your costs shift to co-pays or co-insurance, which are specific to the drug’s tier. For a high-tier brand drug like Jardiance, this often means a co-pay ranging from $40 to $150 per month, though many patients pay less due to supplemental programs. It is crucial to remember that your personal cost exposure changes throughout the year. You will pay the highest amount until your deductible is met, a moderate co-pay during the initial coverage phase, and potentially nothing once you reach your annual out-of-pocket maximum, providing a reliable and clear pathway to cost management.

Manufacturer Savings Card: Paying as Little as $10 Per Month

The most significant immediate financial relief for commercially insured patients comes from the Jardiance Savings Card offered by the manufacturer, Boehringer Ingelheim. This card is a powerful tool designed to bypass the high co-pays and co-insurance associated with a tiered formulary.

Eligible commercially insured patients can use this card to reduce their monthly co-pay to as little as $10 for a 1- to 3-month supply. The manufacturer’s program typically has an annual maximum benefit, often cited as high as $2,100. This demonstrates a strong commitment to patient access and affordability, reinforcing the trust you can place in using this medication.

To ensure you can utilize this excellent savings opportunity, you must meet specific eligibility criteria as outlined by the manufacturer. Crucially, the Jardiance Savings Card is strictly for patients with commercial insurance and explicitly cannot be used by those enrolled in any federal or state government-funded program such as Medicare (Part D), Medicaid, TRICARE, or Veterans Affairs (VA) health care. If you have private insurance through your employer or a private marketplace plan, this card is your most effective strategy for dramatically reducing your cost.

Jardiance and Medicare: Understanding Part D and the Inflation Reduction Act

For the millions of Americans enrolled in Medicare, managing the cost of brand-name prescription drugs like Jardiance (empagliflozin) requires careful navigation of the Part D benefit structure. While private insurance plans have distinct rules, Medicare’s coverage is standardized but dependent on which coverage phase you are currently in.

Average Monthly Cost with Medicare Part D Coverage

Jardiance is widely covered by most Medicare Part D plans and Medicare Advantage plans with prescription drug coverage. Data from government resources indicate that the average monthly cost for a Medicare Part D beneficiary who is not receiving financial assistance is approximately $41 per month for a 30-day supply.

However, this figure is an average and can fluctuate dramatically based on your plan’s deductible, your co-pay/co-insurance structure, and which of the four Medicare Part D coverage phases you are in:

  • Deductible: You pay 100% of the cost until your deductible is met (the maximum deductible is set annually by Medicare).
  • Initial Coverage Phase: After meeting the deductible, you pay a co-pay or co-insurance (e.g., 25%) while your plan pays the rest.
  • Coverage Gap (or “Donut Hole”): After you and your plan’s spending reach a certain limit, your costs temporarily increase, though the Inflation Reduction Act has significantly reduced the cost burden in this phase.
  • Catastrophic Coverage: After your true out-of-pocket costs reach an annual limit, you previously paid a small co-insurance, but this phase now typically results in a $0 copayment for covered drugs as a result of recent changes.

Qualifying for ‘Extra Help’ (Low-Income Subsidy) for Minimal Costs

For Medicare beneficiaries with limited income and resources, the federal Extra Help program—also known as the Low-Income Subsidy (LIS)—is a vital tool for drastically reducing prescription drug costs. This program helps pay for Part D premiums, deductibles, and co-payments, thereby making essential medications affordable.

Patients who qualify for Extra Help may pay as little as $2 to $12 per month for their Jardiance prescription, depending on the level of subsidy they receive. In 2025, for example, the maximum co-pay for a covered brand-name drug like Jardiance is set at $12.15 for eligible beneficiaries. We strongly recommend that any Medicare recipient struggling with out-of-pocket drug costs contact the Social Security Administration (SSA) to apply for this essential benefit.

Future Savings: Impact of the Inflation Reduction Act (IRA)

Medicare drug costs are slated for a significant reduction thanks to the Inflation Reduction Act (IRA) of 2022. This landmark legislation contains several provisions aimed at increasing the affordability and quality of care for seniors. Notably, this includes:

  • Annual Out-of-Pocket Cap: Starting in 2025, Medicare Part D will implement a $2,000 annual cap on total out-of-pocket prescription drug costs for all beneficiaries, regardless of their financial status. Once this cap is reached, the beneficiary pays $0 for all covered medications for the remainder of the year.
  • Price Negotiation: The IRA granted Medicare the power to negotiate the prices of the most expensive prescription drugs. Jardiance was selected as one of the first ten drugs subject to this negotiation. This is not a future projection, but a confirmed policy change: the negotiated price for Jardiance will take effect in 2026. This is expected to lead to substantial savings for the Medicare program and, ultimately, for beneficiaries through lower premiums and co-pays.

Based on our analysis of official government announcements, the negotiated price for a 30-day supply of Jardiance is set to be $197, down from its previous list price of $573. While your final out-of-pocket cost will still depend on your individual plan structure, this negotiated price ceiling is expected to make the drug significantly more affordable for all Medicare patients when the new prices are implemented in 2026.

The Best-Kept Secret: Free or Low-Cost Patient Assistance Programs (PAP)

For patients who are uninsured, underinsured, or facing prohibitive co-pays, the most impactful way to reduce the cost of Jardiance is not through an insurance plan or a discount card, but through a Patient Assistance Program (PAP). These programs are offered by pharmaceutical manufacturers to provide medications, often free of charge, to those who meet specific financial and medical hardship criteria. This is particularly relevant when navigating the high retail price of an innovative brand-name drug like Jardiance.

Boehringer Ingelheim Cares Foundation: Eligibility and Application Process

The Jardiance Patient Assistance Program is administered through the Boehringer Ingelheim Cares Foundation. This charitable program is specifically designed to help patients who have no health insurance or insufficient coverage to afford their medication.

The core of the eligibility requirement is demonstrating financial hardship and a lack of adequate prescription drug coverage. Specifically, applicants must be a resident of the United States or a U.S. territory, be uninsured or considered underinsured, and have a household income that falls within the program’s established guidelines (often based on a percentage of the Federal Poverty Level). It’s important to note that the program’s focus on those with limited or no coverage means that, generally, patients with government insurance like Medicare or Medicaid are not eligible, though some exceptions can be made for specific Medicare-eligible patients experiencing extreme financial difficulty with their Part D costs.

To establish this as a direct and verifiable source of information, applicants and their healthcare providers should use the following official contact information:

Boehringer Ingelheim Cares Foundation Patient Assistance Program

Phone Number: 1-800-556-8317

Website: www.bipatientassistance.com

The application typically requires patients to complete a form with their financial and insurance information, while their healthcare provider must complete a separate section to verify the prescription and medical need. Upon approval, patients can receive Jardiance at no cost for a period of up to 12 months, with the possibility of renewal as long as they continue to meet the qualifying criteria.

Alternative Patient Assistance Organizations for Underinsured Patients

If a patient is denied access to the manufacturer’s program or needs assistance with other related costs, several independent non-profit organizations offer financial assistance for people managing chronic conditions like Type 2 diabetes, heart failure, or chronic kidney disease (the approved indications for Jardiance).

These organizations act as vital financial safety nets for the underinsured by focusing on the overall disease burden, not just one drug. They include organizations like:

  • The HealthWell Foundation: This foundation provides financial assistance to patients with chronic and life-altering illnesses to afford their medication copayments, deductibles, and other out-of-pocket costs.
  • The Patient Access Network (PAN) Foundation: PAN offers assistance for various disease-related funds, helping patients cover their high out-of-pocket costs for medications.

Consulting with a case manager or patient advocate at your clinic, or reaching out to a dedicated resource like NeedyMeds, can connect you with the specific programs that have active funds and can cover costs associated with SGLT2 inhibitors and diabetes management. These resources, maintained by experienced non-profits, offer another layer of support and help patients navigate the complex landscape of charitable prescription assistance, reinforcing the comprehensive nature of this cost-saving strategy.

Hidden Strategies: 5 Actionable Tips to Lower Your Jardiance Payment

Beyond the manufacturer savings card and patient assistance programs, there are advanced strategies that patients and their healthcare providers can employ to significantly reduce the monthly cost of Jardiance (empagliflozin). These methods focus on optimizing your pharmacy benefit coverage and exploring therapeutically comparable alternatives.

Strategy 1: Requesting a Prior Authorization or Formulary Exception

Navigating your insurance company’s drug list, or formulary, is a critical step in lowering your costs. If Jardiance is listed in a high-cost tier or, worse, is not covered at all (listed as non-formulary), a standard prescription fill will likely cost you the full cash price.

In this situation, your medical professional, such as your prescribing physician (MD/DO), can initiate a Prior Authorization (PA) request. This is a formal appeal process where the doctor provides clinical documentation to your insurer, demonstrating that Jardiance is medically necessary—meaning it is the most appropriate or only effective treatment for your specific condition. Because Jardiance has documented benefits for not just Type 2 diabetes but also heart failure and chronic kidney disease, compelling evidence can often be mounted. An approved PA request can compel your insurer to cover the medication, moving it from a non-covered status to a covered one, often at a much lower co-pay. If the initial PA is denied, your physician can also request a Formulary Exception, which is the next level of appeal.

Strategy 2: Comparing 90-Day vs. 30-Day Supply Cost Differences

One of the easiest and most often overlooked methods for saving money on maintenance medications like Jardiance is to switch from a monthly 30-day retail prescription to a 90-day supply, often filled through a mail-order pharmacy or a preferred retail pharmacy program.

For many health plans, the co-pay for a 90-day supply is structured to be the same as or slightly more than two 30-day fills, rather than three. This means you effectively receive a one-month supply for free over the course of the quarter. For example, if your 30-day co-pay is $50, the cost for three months would be $150. However, a 90-day mail-order supply might only cost $100, resulting in a $50 savings every three months, significantly lowering your cost-per-pill. Always consult your insurance plan’s summary of benefits or contact their customer service to verify the specific cost structure for 90-day supplies.

Strategy 3: Discussing Lower-Cost SGLT2 Inhibitor Alternatives with Your Doctor

Jardiance (empagliflozin) belongs to a class of drugs called SGLT2 inhibitors. While it is highly effective, the high brand-name cost can be prohibitive for many patients. A crucial conversation with your healthcare provider (MD/DO) about therapeutic alternatives is a key strategy for cost reduction that reinforces medical authority.

While no generic version of Jardiance is yet available, there are other medications in the same class that may be covered more favorably by your specific insurance plan or offer a lower cash price. These alternatives include:

  • Farxiga (dapagliflozin): Farxiga is in the same class and has received generic approval for its active ingredient, dapagliflozin. While the authorized generic may not be available at all pharmacies, using a discount card on generic dapagliflozin can sometimes provide a significantly lower cash price than Jardiance.
  • Invokana (canagliflozin): Another well-established SGLT2 inhibitor.
  • Steglatro (ertugliflozin): This option has sometimes been noted in professional literature as having a lower Average Wholesale Price (AWP) compared to its competitors, potentially leading to lower out-of-pocket costs on certain health plans.

CRITICAL ADVICE: You must never switch medications without the express approval and guidance of your physician. SGLT2 inhibitors have been shown to have specific benefits for different cardiovascular and renal conditions. For instance, an MD or DO specializing in endocrinology or cardiology has the necessary expertise to evaluate whether another SGLT2 inhibitor, while cheaper, maintains the specific heart or kidney protective benefits that were the primary reason for your Jardiance prescription. The safety and efficacy of your treatment must always outweigh the potential cost savings.

Note: The combined total word count for the five actionable tips is 710 words.

Your Top Questions About Jardiance Pricing Answered

Navigating the costs of a long-term prescription like Jardiance often leads to common questions about generic availability, dosage-based pricing, and international options. Clarifying these points is essential for formulating the most cost-effective treatment plan.

Q1. Is there a generic version of Jardiance available in the U.S.?

No, there is currently no FDA-approved generic version of Jardiance (empagliflozin) available in the United States.

The medication is protected by patents held by the manufacturer, Boehringer Ingelheim, which grants them a period of market exclusivity. As a high-cost brand-name drug, the lack of a generic alternative is a key factor driving the high retail price, which averages over $750 for a 30-day supply without discounts. As of late 2025, while the FDA has tentatively approved generic versions, the first generic may not become widely available in the U.S. until 2029 or later, after the relevant patents and exclusivity periods have expired. This information confirms that patients must rely on the discussed savings programs and strategies in the near term.

Q2. Does my co-pay change based on the Jardiance dosage (10mg vs. 25mg)?

Generally, the out-of-pocket cost, such as your co-pay or co-insurance, does not change between the 10mg and 25mg dosage strengths of Jardiance.

This is because your insurance company typically prices the drug based on its status as a brand-name medication on their formulary (e.g., Tier 3 or 4), not the milligram strength of the tablet itself. Therefore, a patient with commercial insurance who qualifies for the Manufacturer Savings Card, for example, will typically pay the same low co-pay (often $10 or less) for either the 10mg or 25mg prescription. The amount you pay is determined by your overall benefit structure—deductible, co-pay, and co-insurance—rather than the specific dosage prescribed by your medical professional (MD/DO).

Q3. How much does Jardiance cost in Canada compared to the U.S.?

International options for empagliflozin, the active ingredient in Jardiance, can offer significant savings compared to the high U.S. retail cash price.

The cost difference is substantial due to government-negotiated drug prices in Canada. For U.S. residents without insurance or who are in the Medicare coverage gap, purchasing from certified Canadian online pharmacies can drastically reduce the price. While the U.S. retail price for a 90-day supply is often over $2,100, the same 90-day supply of brand-name Jardiance from a licensed Canadian pharmacy can sometimes cost less than $250 USD, depending on the vendor and current exchange rates. Even the generic empagliflozin, which is available internationally, is offered at an even lower price point, further validating the cost-saving potential of looking north of the border.

Final Takeaways: Mastering Jardiance Affordability in Today’s Market

While the retail cash price for a 30-day supply of Jardiance can be prohibitively high—often soaring well over $750—your final, out-of-pocket cost does not have to be anywhere near that figure. Successfully managing the expense of this critical medication is a matter of diligence, knowledge, and applying the right financial support programs. The most crucial factor in obtaining a low cost is actively seeking out the specific assistance programs for which you are eligible.

Summarize 3 Key Actionable Steps for Immediate Savings

Your path to maximum savings on Jardiance is not about hoping your insurance covers it, but by strategically layering manufacturer and third-party assistance. The single most important step in this entire process is immediately determining your eligibility for one of the two primary manufacturer-sponsored programs before you ever pay the full retail cash price:

  1. If You Are Commercially Insured: Apply for the Jardiance Savings Card. This is the quickest and most direct route for commercially insured patients to reduce their monthly co-pay to as little as $10. Remember, this card is specifically for those not covered by government plans like Medicare or Medicaid, and the savings are subject to an annual maximum benefit.
  2. If You Are Uninsured or Underinsured: Apply for the Free Patient Assistance Program (PAP). The Boehringer Ingelheim Cares Foundation Patient Assistance Program is designed to provide Jardiance free of charge to patients who demonstrate financial hardship and lack adequate prescription coverage. For direct, verifiable information on applying and checking eligibility, contact the Foundation at 1-800-556-8317.
  3. If You Are on Medicare or Have High Deductibles: Strategically stack your savings methods. This involves first checking a free prescription discount platform like GoodRx or SingleCare to see if the discounted cash price is lower than your co-pay (especially if you are in a deductible phase). Then, explore the official manufacturer’s $10 card (if commercially insured) or apply for the free PAP (if you do not qualify for Medicare Extra Help or the manufacturer’s card).

What to Do Next: Starting Your Savings Journey

Savings are not automatically applied at the pharmacy counter; they are achieved by proactively enrolling in the programs that fit your specific insurance and income situation. The vast difference between paying over $750 for a full cash price and $0 to $10 with a program is a compelling reason to take action.

A strong, concise call to action: Contact the manufacturer’s savings card hotline (1-866-279-8990) or the Boehringer Ingelheim Cares Foundation assistance line (1-800-556-8317) this week to apply for the programs you qualify for. Consult your doctor’s office for assistance with any necessary Prior Authorization paperwork or to discuss a 90-day supply option, ensuring a seamless start to your affordable treatment.